Schedule 13G ownership disclosure

Protalix BioTherapeutics, Inc.

Security class unavailable · CUSIP: 74365A101

Event date: 2015-10-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,649,079
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-15-000046
Form type
SC 13G
Filer
PFIZER INC
CIK
CIK 78003
Filed
Oct 23, 2015
Reporting period
Oct 13, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub